• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Plasma Exchange Does Not Reduce Risk of Death for Patients with Severe ANCA-Associated Vasculitis

The underlying pathology behind antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is not clear; more effective and safer treatments are needed.  High-dose…

February 18, 2020

Final FDA Guidance to Reduce Transfusion-Transmitted Human T-Lymphotropic Virus Types I and II

Transmission of the retroviruses human T-lymphotropic virus types I and II (HTLV-I/II) require cell-to-cell contact—mother to child transmission, sexual transmission,…

February 12, 2020

New Draft Guidance Recommendations from the FDA to Reduce Risk of Transfusion-Transmitted Creutzfeldt-Jakob Diseases

Creutzfeldt-Jakob Disease (CJD) is a fatal, rare neurological disease caused by infectious prions, or abnormally folded proteins.  Sporadic CJD accounts…

February 5, 2020

World on Heightened Alert for Novel Coronavirus

Coronaviruses are a large family of enveloped RNA zoonotic viruses. The emerging novel coronavirus from Wuhan, China that was first…

January 28, 2020

Erythropoietin Does Not Provide Neuroprotection in Preterm Infants

In addition to stimulating red blood cell production, erythropoietin is a trophic factor in fetal brain development. Meta-analysis of four…

January 22, 2020

New Drug, Enasidenib, Enhances Erythroid Differentiation and Lessens Anemia

Enaisdenib inhibits isocitrate dehygrogenase 2 (IDH2)-mutant activity and was approved by the FDA in 2017 for patients with refractory or…

January 15, 2020

Gene Therapy for Hemophilia A Decreases Bleeding

Adeno-associated virus (AAV)-mediated gene therapy is a promising new treatment for hemophilia A which decreases bleeding and thus risk of…

January 8, 2020

Platelet Transfusion Use in the United States

Although RBC transfusions have decreased over the past decade, the demand for platelet transfusions has increased.   In order to better…

December 30, 2019

Mechanisms and Implications of Why Platelet Transfusions May Not Always Be Effective

Platelet transfusions are not always effective at preventing bleeding in patients with inherited and acquired platelet disorders such as Glanzmann’s…

December 18, 2019

Decreases in U.S. Blood Donors Despite Increases in Eligible Donors

Although the number of RBC and whole blood cell transfusions has decreased by approximately 10% over the last decade, there…

December 12, 2019

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Interim pages omitted …
  • Page 62
  • Go to Next Page »

Primary Sidebar

Latest News

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley